RSS

EXPI eXp Realty International Corp

Mod: eXpCEO
Last Post: 11/26/23
Followers: 4
Posts Today: 0
Views Today: 6554

EXPI Stock Quote & Tools

EXPI Stock Message Board Discussion

Top 10 Most Recent News Articles

Candel’s BLA Delay Puts Disclosure Timing Under Fire

Updated Category News Views 118

A December filing turned into a mid-2027 wait, and Candel shareholders absorbed the damage in one ugly trading session. On November 13, shares of Candel Therapeutics fell 26% after the company disclosed that its biologics license application, or BLA, for aglatimagene in prostate cancer was no longer expected in December 2026. The revised plan is to submit in the middle of...

Continue Reading
NetEase Margins Hold Firm as Game Revenue Slips Again

Updated Category News Views 45

A game publisher can look tired at the top line and still be doing plenty right underneath the hood. NetEase’s third-quarter 2026 report is that kind of animal: revenue eased, yet costs behaved, profit rebounded from the prior quarter, and the balance sheet remains absurdly well stocked. For investors in NASDAQ:NTES, this was not a clean victory lap. It was a reminder...

Continue Reading
Pennsylvania Rebate Rules Matter Before Year-End Filing

Updated Category News Views 80

A missed rebate form can sting harder than most people expect, especially when a household has already spent the year watching property taxes, rent, groceries, and every other stubborn bill chew through fixed income. Pennsylvania’s Property Tax/Rent Rebate Program is not glamorous, and it is certainly not an investing story. It is, however, the kind of direct household...

Continue Reading
Vizsla's Panuco Delay Puts Security Ahead of Speed

Updated Category News Views 122

A mine schedule can absorb a calendar slip; the people around a mine cannot be treated like a line item. Vizsla Silver's update on Panuco is therefore not the usual development-company chest thumping. It is a sober admission that security, permitting and site readiness have pushed first silver to the second half of 2028, one year later than the prior H2 2027 target....

Continue Reading
Tigerlily Takes Its Advocacy Model to Ovarian Cancer

Updated Category News Views 166

Ovarian cancer has a nasty habit of hiding behind symptoms people are taught to shrug off. Persistent bloating or pelvic pain can look like any number of ordinary problems, and that ambiguity is exactly why practical, trusted education matters. Tigerlily Foundation's new ovarian cancer initiative is not a flashy breakthrough claim. It is a grounded attempt to help women...

Continue Reading
APEC in Shenzhen Puts Trade Openness Back in Focus

Updated Category News Views 103

Shenzhen is hosting a familiar but consequential argument: prosperity gets harder to share when trade channels clog up. At the 33rd Asia-Pacific Economic Cooperation Economic Leaders' Meeting on November 18, President Xi Jinping used the opening of the APEC CEO Summit to argue for peace, openness, innovation, mutual benefit and support for the WTO-centered multilateral...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Allstate's October Cat Loss Lands at $232 Million Net

Updated Category News Views 75

October’s weather bill arrived without much poetry: $232 million in estimated catastrophe losses at Allstate. Reported on November 19, that figure falls to $184 million after tax, and it deserves a clear-eyed read rather than the usual insurance-stock theatrics. A single monthly catastrophe tally is not a verdict on the company, but it is absolutely part of the...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 109

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 46

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading

Top 5 Most Recently Viewed Articles

Whataburger Announces Leadership Transition with New CEO

Updated Category News Views 664

Whataburger Announces CEO Retirement and Leadership Transition Whataburger is making headlines with the news that Chief Executive Officer Ed Nelson will retire at the end of this year. This marks the conclusion of a significant chapter in the company’s journey. Over his two-decade tenure, Ed's leadership has profoundly impacted Whataburger's growth and expansion. Ed...

Continue Reading
Important Insights on BBAI Class Action and Shareholder Rights

Updated Category News Views 255

Understanding the Class Action Lawsuit for BigBear.ai Holdings, Inc. BigBear.ai Holdings, Inc. (NYSE: BBAI) is currently facing legal scrutiny as a class action lawsuit has been filed on behalf of shareholders who purchased the company's securities between specific periods of interest. Legal representatives are urging shareholders who believe they were adversely affected...

Continue Reading
Piramal Pharma Limited Delivers Strong Financial Growth in FY25

Updated Category News Views 480

Piramal Pharma Limited Announces Impressive Q2 and H1 FY25 Results Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635), a prominent player in the global pharmaceuticals and wellness industry, has reported its financial results for the Second Quarter (Q2) and Half Year (H1) of FY25, indicating a notable upward trend in its performance. Financial Highlights from Q2 FY25...

Continue Reading
Foresee Pharmaceuticals Launches Phase 2 Study for Mirivadelgat

Updated Category News Views 221

Foresee Pharmaceuticals Advances Treatment Options for PH-ILD Foresee Pharmaceuticals has recently marked a significant milestone by announcing the dosing of the first patient in its Phase 2 WINDWARD study. This critical study aims to assess the efficacy and safety of mirivadelgat, a novel oral medication designed for individuals suffering from pulmonary...

Continue Reading
Suki Secures $70 Million to Enhance AI Healthcare Solutions

Updated Category News Views 101

Suki's Impressive Funding Round Suki, an innovative healthcare startup, has successfully raised $70 million in its Series D funding round. This funding brings the company's total capital raised to an impressive $165 million. The news marks a significant step forward for Suki as it seeks to enhance its AI-assisted offerings aimed at reducing the administrative burdens...

Continue Reading